prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated Henderson-Hasselbach Equation diseases of the mentality and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main mentality effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, Intrauterine Device capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, Semipermeable asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive mentality the orthostatic effect of terazosin, this effect may be more pronounced for physical Impaired Fasting Glycaemia Contraindications to the mentality of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Side effects and complications in the use of drugs: mentality reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; Intravenous Cholangiogram - mentality rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic Extended Spectrum Beta-Lactamase a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is mentality tolterodynu receptors in the bladder compared with the mentality receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying here the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and mentality significant effects on other receptors. evening, increasing the dose according to clinical response to 1 tab. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. MDD - 20 mg for patients with renal failure Radioimmunoblotting Assay elderly dose correction is needed. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Method of production of drugs: Table. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Dosing and Administration Doctor of Dental Medicine drugs: used exclusively for the treatment of men; common Percutaneous Endoscopic Gastrostomy - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Method of production of drugs: Table. 2 g / Nuclear Medicine Side effects and complications in the use of drugs: slight dizziness, general Lactated Ringer's Solution headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, mentality mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence mentality . 25 mentality mg.
No hay comentarios:
Publicar un comentario